(Q48546465)

12 February 2018

title

Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis (English)

1 reference

12 February 2018

relapsing-remitting multiple sclerosis

main subject

0 references

multiple sclerosis

0 references

cognitive dysfunction

1 reference

3

1 reference

12 February 2018

author name string

Mathias Sundgren

1

1 reference

12 February 2018

Liselotte Maurex

2

1 reference

12 February 2018

Fredrik Piehl

4

1 reference

12 February 2018

Tom Brismar

5

1 reference

12 February 2018

publication date

4 January 2013

1 reference

12 February 2018

Archives of Clinical Neuropsychology

published in

1 reference

12 February 2018

volume

28

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

144-155

1 reference

12 February 2018

High nationwide prevalence of multiple sclerosis in Sweden.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Estimation of premorbid cognitive function based on word knowledge: the Swedish Lexical Decision Test (SLDT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Fatigue and processing speed are related in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Depression in multiple sclerosis: review and theoretical proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The Goldman Consensus statement on depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive and neurobehavioral features in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Relationship between global cognitive decline and depressive symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The psychology of fatigue in patients with multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Mood disorders in multiple sclerosis and the effects on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive impairment and decline in different MS subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

A prospective study of patterns of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The relationship between perceived and objective cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Treatment of depression for patients with multiple sclerosis in neurology clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive impairment in different MS subtypes and clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

The neuropsychology of depression: a literature review and preliminary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Depression in multiple sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

An examination of four models predicting fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Intellectual and physical performance and morbidity in relation to height in a cohort of 18-year-old Swedish conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

SSRIs and cognitive performance in a working sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FARCLIN%2FACS113

21 January 2018

Identifiers

DOI

10.1093/ARCLIN/ACS113

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f4ctcpqrkvenfa3c25y24j4k34

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_f4ctcpqrkvenfa3c25y24j4k34

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f4ctcpqrkvenfa3c25y24j4k34

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/f4ctcpqrkvenfa3c25y24j4k34

1 reference